You can buy or sell PSTI and other stocks, options, and ETFs commission-free!
Pluristem Therapeutics, Inc. Common Stock, also called Pluristem Therapeutics, is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The firm focuses on the development, clinical trials and manufacturing of cell therapeutics and related technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel. The listed name for PSTI is Pluristem Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected May 10, After Hours